Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis

Therapeutic Drug Monitoring
E B WilmsH G M Heijerman

Abstract

Chronic therapy with the macrolide antibiotic azithromycin (AZM) is widely practiced in the treatment of patients with cystic fibrosis (CF) and chronic lung infection with Pseudomonas aeruginosa. Azithromycin dosage is variable, based on published studies, and not supported by pharmacokinetic data. This study describes the pharmacokinetics of the long-term administration of AZM (500 mg per day) in CF patients. AZM concentrations were quantified in the plasma, blood, isolated polymorphonuclear neutrophils (PMNNs), and sputum of 8 adult CF patients. The AZM distribution t1/2 was 0.1 hours in plasma. The (mean +/- standard deviation) elimination t(1/2) was 102 +/- 20 hours in plasma, 180 +/- 68 hours in blood, and 289 +/- 166 hours in PMNNs. The C(max) of AZM was 0.67 +/- 0.31 mg/L in plasma and 2.01 +/- 0.74 mg/L in blood, of which 1.44 +/- 0.69 mg/L was found in PMNNs. In sputum the concentration of AZM ranged from 12 to 53 mg/L and was still detectable at concentrations in the range 4 to 27 mg/L 10 days after the last dose. On average, the concentration in PMNNs was 2100 times the C(plasma) 24 hours after dosing AZM. These results confirm the accumulation of AZM in PMNNs. The authors conclude that sputum levels are elevated far...Continue Reading

References

Oct 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D L MorrisW E Morgan
May 8, 1990·Journal of Immunological Methods·P H NibberingR Van Furth
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·R P Gladue, M E Snider
Sep 15, 1974·Biochemical Pharmacology·C de DuveF Van Hoof
Apr 22, 1981·Biochimica Et Biophysica Acta·M HollemansJ M Tager
Mar 1, 1993·The Journal of Antimicrobial Chemotherapy·T MazzeiP Periti
Oct 1, 1996·Antimicrobial Agents and Chemotherapy·K B PatelC H Nightingale
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·K M OlsenG D Campbell
May 17, 2001·Antimicrobial Agents and Chemotherapy·G L Mandell, E Coleman
May 17, 2001·Antimicrobial Agents and Chemotherapy·K TatedaC Van Delden
May 22, 2001·Clinical and Experimental Immunology·C HubeauD Gaillard
Nov 17, 2001·International Journal of Antimicrobial Agents·W L Hand, D L Hand
Aug 7, 2002·Clinical Reviews in Allergy & Immunology·Clement L Ren
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Lisa SaimanUNKNOWN Macrolide Study Group

❮ Previous
Next ❯

Citations

Nov 23, 2011·European Journal of Clinical Pharmacology·P ZarogoulidisK Zarogoulidis
Aug 2, 2011·The Journal of Clinical Investigation·Maurizio RennaR Andres Floto
Feb 16, 2010·Expert Opinion on Investigational Drugs·D M MurphyC Ward
Dec 8, 2009·Archivos de bronconeumología·Daniel Sevilla-SánchezNéstor Soler-Porcar
May 1, 2007·Clinics in Chest Medicine·John R McArdle, Jaideep S Talwalkar
Mar 19, 2014·Pharmacology & Therapeutics·Michael J ParnhamRobin Vos
Jan 15, 2014·British Journal of Pharmacology·V BalloyL Guillot
Mar 26, 2013·Respiratory Medicine·K Suresh BabuJ B Morjaria
Mar 14, 2012·International Immunopharmacology·Syh-Jae LinPei-Yzu Lee
Jun 30, 2007·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·E B WilmsH G M Heijerman
Aug 15, 2008·Respiratory Medicine·Gratiana SteinkampStefan Zielen
May 6, 2014·Frontiers in Microbiology·Francesco ImperiPaolo Visca
Oct 25, 2016·International Immunopharmacology·Syh-Jae LinPei-Tzu Lee
May 21, 2011·International Archives of Allergy and Immunology·Syh-Jae LinMing-Ling Kuo
Jan 25, 2017·Postgraduate Medicine·Cassondra L CramerAyman O Soubani
Dec 17, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M PainUNKNOWN COLT Consortium
Feb 5, 2010·Ocular Immunology and Inflammation·Paul S CheungKamran Hosseini
Oct 23, 2009·British Journal of Pharmacology·Catherine M Greene, Noel G McElvaney
Sep 4, 2015·Pediatric Pulmonology·David P Nichols, James F Chmiel
Jul 19, 2016·Clinical Medicine Insights. Pediatrics·Corinne A MuirheadKelvin D MacDonald
Sep 25, 2020·Reviews in Medical Virology·Madeleine E Oliver, Timothy S C Hinks
May 26, 2017·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Markus WeckmannMatthias V Kopp
Jul 28, 2020·The Journal of Small Animal Practice·E PerryG Zur
Nov 4, 2020·Antimicrobial Agents and Chemotherapy·Tara GallagherKatrine L Whiteson
Mar 2, 2021·Frontiers in Immunology·Vincent J VendittoDavid J Feola
Aug 18, 2020·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Jennifer L Taylor-CousarEdward F Nash
Jun 13, 2021·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Kim ThomsenClaus Moser
Aug 31, 2021·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Raksha JainJennifer L Taylor-Cousar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.